Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Anticancer Drug Market Insights, Forecast to 2030

Global Anticancer Drug Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-04-19

Pages: 95 Pages

Report ld: 2985355

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.

Market Analysis and Insights: Global Anticancer Drug Market

Anticancer Drug Market Size

M= millions and B=billions

The global Anticancer Drug market is projected to grow from US$ 104850 million in 2024 to US$ 154730 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:
This report presents an overview of global market for Anticancer Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anticancer Drug, also provides the revenue of main regions and countries. of the upcoming market potential for Anticancer Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anticancer Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Anticancer Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Anticancer Drug revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche, Celgene, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceuticals, Bayer and GlaxoSmithKline, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Anticancer Drug Market Insights, Forecast to 2030
Forecasted Market Size in 2030
US$ 154730 million
CAGR(2024-2030)
6.7%
Market Size Available for Years
2019-2030
Global Anticancer Drug Companies Covered
Roche, Celgene, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceuticals, Bayer, GlaxoSmithKline
Global Anticancer Drug Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticancer Drug Market, Segment by Type
Targeted Drugs

Cytotoxic Drugs

Hormonal Drugs

Others
Global Anticancer Drug Market, Segment by Application
Immunotherapy

Targeted Therapy

Chemotherapy

Hormonal Therapy

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Anticancer Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anticancer Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anticancer Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anticancer Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Targeted Drugs
        1.2.3 Cytotoxic Drugs
        1.2.4 Hormonal Drugs
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Anticancer Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Immunotherapy
        1.3.3 Targeted Therapy
        1.3.4 Chemotherapy
        1.3.5 Hormonal Therapy
        1.3.6 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Anticancer Drug Market Perspective (2019-2030)
    2.2 Global Anticancer Drug Growth Trends by Region
        2.2.1 Anticancer Drug Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Anticancer Drug Historic Market Size by Region (2019-2024)
        2.2.3 Anticancer Drug Forecasted Market Size by Region (2025-2030)
    2.3 Anticancer Drug Market Dynamics
        2.3.1 Anticancer Drug Industry Trends
        2.3.2 Anticancer Drug Market Drivers
        2.3.3 Anticancer Drug Market Challenges
        2.3.4 Anticancer Drug Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Revenue Anticancer Drug by Players
        3.1.1 Global Anticancer Drug Revenue by Players (2019-2024)
        3.1.2 Global Anticancer Drug Revenue Market Share by Players (2019-2024)
    3.2 Global Anticancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Anticancer Drug, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Anticancer Drug Market Concentration Ratio
        3.4.1 Global Anticancer Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anticancer Drug Revenue in 2023
    3.5 Global Key Players of Anticancer Drug Head office and Area Served
    3.6 Global Key Players of Anticancer Drug, Product and Application
    3.7 Global Key Players of Anticancer Drug, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Anticancer Drug Breakdown Data by Type
    4.1 Global Anticancer Drug Historic Market Size by Type (2019-2024)
    4.2 Global Anticancer Drug Forecasted Market Size by Type (2025-2030)

 5 Anticancer Drug Breakdown Data by Application
    5.1 Global Anticancer Drug Historic Market Size by Application (2019-2024)
    5.2 Global Anticancer Drug Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Anticancer Drug Market Size (2019-2030)
    6.2 North America Anticancer Drug Market Size by Type
        6.2.1 North America Anticancer Drug Market Size by Type (2019-2024)
        6.2.2 North America Anticancer Drug Market Size by Type (2025-2030)
        6.2.3 North America Anticancer Drug Market Share by Type (2019-2030)
    6.3 North America Anticancer Drug Market Size by Application
        6.3.1 North America Anticancer Drug Market Size by Application (2019-2024)
        6.3.2 North America Anticancer Drug Market Size by Application (2025-2030)
        6.3.3 North America Anticancer Drug Market Share by Application (2019-2030)
    6.4 North America Anticancer Drug Market Size by Country
        6.4.1 North America Anticancer Drug Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Anticancer Drug Market Size by Country (2019-2024)
        6.4.3 North America Anticancer Drug Market Size by Country (2025-2030)
        6.4.4 U.S.
        6.4.5 Canada

 7 Europe
    7.1 Europe Anticancer Drug Market Size (2019-2030)
    7.2 Europe Anticancer Drug Market Size by Type
        7.2.1 Europe Anticancer Drug Market Size by Type (2019-2024)
        7.2.2 Europe Anticancer Drug Market Size by Type (2025-2030)
        7.2.3 Europe Anticancer Drug Market Share by Type (2019-2030)
    7.3 Europe Anticancer Drug Market Size by Application
        7.3.1 Europe Anticancer Drug Market Size by Application (2019-2024)
        7.3.2 Europe Anticancer Drug Market Size by Application (2025-2030)
        7.3.3 Europe Anticancer Drug Market Share by Application (2019-2030)
    7.4 Europe Anticancer Drug Market Size by Country
        7.4.1 Europe Anticancer Drug Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Anticancer Drug Market Size by Country (2019-2024)
        7.4.3 Europe Anticancer Drug Market Size by Country (2025-2030)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

 8 China
    8.1 China Anticancer Drug Market Size (2019-2030)
    8.2 China Anticancer Drug Market Size by Type
        8.2.1 China Anticancer Drug Market Size by Type (2019-2024)
        8.2.2 China Anticancer Drug Market Size by Type (2025-2030)
        8.2.3 China Anticancer Drug Market Share by Type (2019-2030)
    8.3 China Anticancer Drug Market Size by Application
        8.3.1 China Anticancer Drug Market Size by Application (2019-2024)
        8.3.2 China Anticancer Drug Market Size by Application (2025-2030)
        8.3.3 China Anticancer Drug Market Share by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Anticancer Drug Market Size (2019-2030)
    9.2 Asia Anticancer Drug Market Size by Type
        9.2.1 Asia Anticancer Drug Market Size by Type (2019-2024)
        9.2.2 Asia Anticancer Drug Market Size by Type (2025-2030)
        9.2.3 Asia Anticancer Drug Market Share by Type (2019-2030)
    9.3 Asia Anticancer Drug Market Size by Application
        9.3.1 Asia Anticancer Drug Market Size by Application (2019-2024)
        9.3.2 Asia Anticancer Drug Market Size by Application (2025-2030)
        9.3.3 Asia Anticancer Drug Market Share by Application (2019-2030)
    9.4 Asia Anticancer Drug Market Size by Region
        9.4.1 Asia Anticancer Drug Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Anticancer Drug Market Size by Region (2019-2024)
        9.4.3 Asia Anticancer Drug Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

 10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Anticancer Drug Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Anticancer Drug Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Anticancer Drug Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Anticancer Drug Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Anticancer Drug Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Anticancer Drug Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Anticancer Drug Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Anticancer Drug Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Anticancer Drug Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Anticancer Drug Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Anticancer Drug Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Anticancer Drug Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Anticancer Drug Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

 11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Anticancer Drug Introduction
        11.1.4 Roche Revenue in Anticancer Drug Business (2019-2024)
        11.1.5 Roche Recent Developments
    11.2 Celgene
        11.2.1 Celgene Company Details
        11.2.2 Celgene Business Overview
        11.2.3 Celgene Anticancer Drug Introduction
        11.2.4 Celgene Revenue in Anticancer Drug Business (2019-2024)
        11.2.5 Celgene Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Anticancer Drug Introduction
        11.3.4 Pfizer Revenue in Anticancer Drug Business (2019-2024)
        11.3.5 Pfizer Recent Developments
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Anticancer Drug Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Anticancer Drug Business (2019-2024)
        11.4.5 Bristol-Myers Squibb Recent Developments
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Anticancer Drug Introduction
        11.5.4 Novartis Revenue in Anticancer Drug Business (2019-2024)
        11.5.5 Novartis Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Anticancer Drug Introduction
        11.6.4 AstraZeneca Revenue in Anticancer Drug Business (2019-2024)
        11.6.5 AstraZeneca Recent Developments
    11.7 Teva Pharmaceuticals
        11.7.1 Teva Pharmaceuticals Company Details
        11.7.2 Teva Pharmaceuticals Business Overview
        11.7.3 Teva Pharmaceuticals Anticancer Drug Introduction
        11.7.4 Teva Pharmaceuticals Revenue in Anticancer Drug Business (2019-2024)
        11.7.5 Teva Pharmaceuticals Recent Developments
    11.8 Bayer
        11.8.1 Bayer Company Details
        11.8.2 Bayer Business Overview
        11.8.3 Bayer Anticancer Drug Introduction
        11.8.4 Bayer Revenue in Anticancer Drug Business (2019-2024)
        11.8.5 Bayer Recent Developments
    11.9 GlaxoSmithKline
        11.9.1 GlaxoSmithKline Company Details
        11.9.2 GlaxoSmithKline Business Overview
        11.9.3 GlaxoSmithKline Anticancer Drug Introduction
        11.9.4 GlaxoSmithKline Revenue in Anticancer Drug Business (2019-2024)
        11.9.5 GlaxoSmithKline Recent Developments

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Anticancer Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Targeted Drugs
    Table 3. Key Players of Cytotoxic Drugs
    Table 4. Key Players of Hormonal Drugs
    Table 5. Key Players of Others
    Table 6. Global Anticancer Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Anticancer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Anticancer Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Anticancer Drug Market Share by Region (2019-2024)
    Table 10. Global Anticancer Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Anticancer Drug Market Share by Region (2025-2030)
    Table 12. Anticancer Drug Market Trends
    Table 13. Anticancer Drug Market Drivers
    Table 14. Anticancer Drug Market Challenges
    Table 15. Anticancer Drug Market Restraints
    Table 16. Global Anticancer Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Anticancer Drug Revenue Share by Players (2019-2024)
    Table 18. Global Top Anticancer Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drug as of 2023)
    Table 19. Global Anticancer Drug Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Anticancer Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Anticancer Drug, Headquarters and Area Served
    Table 22. Global Key Players of Anticancer Drug, Product and Application
    Table 23. Global Key Players of Anticancer Drug, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anticancer Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Anticancer Drug Revenue Market Share by Type (2019-2024)
    Table 27. Global Anticancer Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Anticancer Drug Revenue Market Share by Type (2025-2030)
    Table 29. Global Anticancer Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Anticancer Drug Revenue Share by Application (2019-2024)
    Table 31. Global Anticancer Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Anticancer Drug Revenue Share by Application (2025-2030)
    Table 33. North America Anticancer Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Anticancer Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Anticancer Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Anticancer Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Anticancer Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Anticancer Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Anticancer Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Anticancer Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Anticancer Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Anticancer Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Anticancer Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Anticancer Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Anticancer Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Anticancer Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Anticancer Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Anticancer Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Anticancer Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Anticancer Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Anticancer Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Anticancer Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Anticancer Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Anticancer Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Anticancer Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Anticancer Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Anticancer Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Anticancer Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Anticancer Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Anticancer Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Anticancer Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Anticancer Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Anticancer Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Anticancer Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Anticancer Drug Product
    Table 68. Roche Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 69. Roche Recent Developments
    Table 70. Celgene Company Details
    Table 71. Celgene Business Overview
    Table 72. Celgene Anticancer Drug Product
    Table 73. Celgene Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 74. Celgene Recent Developments
    Table 75. Pfizer Company Details
    Table 76. Pfizer Business Overview
    Table 77. Pfizer Anticancer Drug Product
    Table 78. Pfizer Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 79. Pfizer Recent Developments
    Table 80. Bristol-Myers Squibb Company Details
    Table 81. Bristol-Myers Squibb Business Overview
    Table 82. Bristol-Myers Squibb Anticancer Drug Product
    Table 83. Bristol-Myers Squibb Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 84. Bristol-Myers Squibb Recent Developments
    Table 85. Novartis Company Details
    Table 86. Novartis Business Overview
    Table 87. Novartis Anticancer Drug Product
    Table 88. Novartis Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 89. Novartis Recent Developments
    Table 90. AstraZeneca Company Details
    Table 91. AstraZeneca Business Overview
    Table 92. AstraZeneca Anticancer Drug Product
    Table 93. AstraZeneca Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 94. AstraZeneca Recent Developments
    Table 95. Teva Pharmaceuticals Company Details
    Table 96. Teva Pharmaceuticals Business Overview
    Table 97. Teva Pharmaceuticals Anticancer Drug Product
    Table 98. Teva Pharmaceuticals Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 99. Teva Pharmaceuticals Recent Developments
    Table 100. Bayer Company Details
    Table 101. Bayer Business Overview
    Table 102. Bayer Anticancer Drug Product
    Table 103. Bayer Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 104. Bayer Recent Developments
    Table 105. GlaxoSmithKline Company Details
    Table 106. GlaxoSmithKline Business Overview
    Table 107. GlaxoSmithKline Anticancer Drug Product
    Table 108. GlaxoSmithKline Revenue in Anticancer Drug Business (2019-2024) & (US$ Million)
    Table 109. GlaxoSmithKline Recent Developments
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anticancer Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Anticancer Drug Market Share by Type: 2023 VS 2030
    Figure 3. Targeted Drugs Features
    Figure 4. Cytotoxic Drugs Features
    Figure 5. Hormonal Drugs Features
    Figure 6. Others Features
    Figure 7. Global Anticancer Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Anticancer Drug Market Share by Application: 2023 VS 2030
    Figure 9. Immunotherapy Case Studies
    Figure 10. Targeted Therapy Case Studies
    Figure 11. Chemotherapy Case Studies
    Figure 12. Hormonal Therapy Case Studies
    Figure 13. Others Case Studies
    Figure 14. Anticancer Drug Report Years Considered
    Figure 15. Global Anticancer Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Anticancer Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Anticancer Drug Market Share by Region: 2023 VS 2030
    Figure 18. Global Anticancer Drug Market Share by Players in 2023
    Figure 19. Global Top Anticancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drug as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Anticancer Drug Revenue in 2023
    Figure 21. North America Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Anticancer Drug Market Share by Type (2019-2030)
    Figure 23. North America Anticancer Drug Market Share by Application (2019-2030)
    Figure 24. North America Anticancer Drug Market Share by Country (2019-2030)
    Figure 25. United States Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Anticancer Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Anticancer Drug Market Share by Type (2019-2030)
    Figure 29. Europe Anticancer Drug Market Share by Application (2019-2030)
    Figure 30. Europe Anticancer Drug Market Share by Country (2019-2030)
    Figure 31. Germany Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Anticancer Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Anticancer Drug Market Share by Type (2019-2030)
    Figure 39. China Anticancer Drug Market Share by Application (2019-2030)
    Figure 40. Asia Anticancer Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Anticancer Drug Market Share by Type (2019-2030)
    Figure 42. Asia Anticancer Drug Market Share by Application (2019-2030)
    Figure 43. Asia Anticancer Drug Market Share by Region (2019-2030)
    Figure 44. Japan Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Anticancer Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Anticancer Drug Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Anticancer Drug Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Anticancer Drug Market Share by Country (2019-2030)
    Figure 54. Brazil Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Anticancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Roche Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 61. Celgene Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 62. Pfizer Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 64. Novartis Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 65. AstraZeneca Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 67. Bayer Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 68. GlaxoSmithKline Revenue Growth Rate in Anticancer Drug Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed

Description

Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.

Market Analysis and Insights: Global Anticancer Drug Market

The global Anticancer Drug market is projected to grow from US$ 104850 million in 2024 to US$ 154730 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.

Descriptive company profiles of the major global players, including Roche, Celgene, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceuticals, Bayer and GlaxoSmithKline, etc.

Market Segmentation